Washington Trust Advisors’s Pulmonx LUNG Stock Holding History

Washington Trust Advisors’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-167	Closed	-$1.13K	–	653
2024 Q4	$1.13K	Hold	167	–	–	﹤0.01%	636
2024 Q3	$1.39K	Hold	167	–	–	﹤0.01%	649
2024 Q2	$1.06K	Hold	167	–	–	﹤0.01%	647
2024 Q1	$1.55K	Hold	167	–	–	﹤0.01%	645
2023 Q4	$2.13K	Hold	167	–	–	﹤0.01%	641
2023 Q3	$1.73K	Hold	167	–	–	﹤0.01%	648
2023 Q2	$2.19K	Hold	167	–	–	﹤0.01%	623
2023 Q1	$1.87K	Hold	167	–	–	﹤0.01%	726
2022 Q4	$1.41K	Hold	167	–	–	﹤0.01%	751
2022 Q3	$3K	Buy	167 +72	+76%	+$1.33K	﹤0.01%	807
2022 Q2	$1K	Hold	95	–	–	﹤0.01%	914
2022 Q1	$2K	Hold	95	–	–	﹤0.01%	952
2021 Q4	$3K	Buy	+95	New	+$3.47K	﹤0.01%	928

Other funds holding LUNG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Washington Trust Advisors's LUNG Position: Q1 2025 in Review

Washington Trust Advisors sold out of Pulmonx (LUNG) in Q1 2025, closing a stake of 167 shares — an estimated $1.13K sold.

Washington Trust Advisors first reported a position in LUNG in Q4 2021 and held it in 13 quarters. The position peaked at $3K in Q3 2022. 115 funds tracked by Wall St. Rank hold LUNG as of Q1 2025.

Washington Trust Advisors reported no remaining Pulmonx position as of Q1 2025 after selling out during the quarter.
Washington Trust Advisors sold 167 Pulmonx shares in Q1 2025, an estimated $1.13K.
Washington Trust Advisors first reported a position in Pulmonx in Q4 2021 and held it in 13 quarters.
Washington Trust Advisors's Pulmonx position peaked at $3K in Q3 2022.
115 funds tracked by Wall St. Rank held Pulmonx as of Q1 2025.

Based on Washington Trust Advisors's 13F filing for Q1 2025, filed 25 Apr 2025.